or
forgot password
  • cancer clinical trials in maumee, OH

  • Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Toledo Clinic Cancer Centers-Maumee
    Maumee, Ohio 43537-1839
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
    Northwest Ohio Oncology Center

    Trial Locations
    Northwest Ohio Oncology Center
    Saint Luke's Hospital
    Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
    Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Toledo Clinic Cancer Centers-Maumee
    Maumee, Ohio 43537-1839
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    St. Luke's Hospital

    Trial Locations
    St. Luke's Hospital
    Northwest Ohio Oncology Center
    Breast Cancer
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    St. Luke's Hospital

    Trial Locations
    St. Luke's Hospital
    Northwest Ohio Oncology Center
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
    Toledo Clinic Cancer Centers-Maumee
    Maumee, Ohio 43537-1839
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
    St. Luke's Hospital

    Trial Locations
    St. Luke's Hospital
    Northwest Ohio Oncology Center
    Leukemia
    Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
    St. Luke's Hospital

    Trial Locations
    St. Luke's Hospital
    Northwest Ohio Oncology Center
    Breast Cancer
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Toledo Clinic Cancer Centers-Maumee
    Maumee, Ohio 43537-1839
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
    Northwest Ohio Oncology Center

    Trial Locations
    Northwest Ohio Oncology Center
    Saint Luke's Hospital
    Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
    Toledo Radiation Oncology at Northwest Ohio Onocolgy Center

    Trial Locations
    Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
    Toledo Clinic Cancer Centers-Maumee
    Neuroendocrine Carcinoma
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Saint Luke's Hospital

    Trial Locations
    Saint Luke's Hospital
    Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
    Toledo Clinic Cancer Centers-Maumee
    Maumee, Ohio 43537-1839
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Saint Luke's Hospital

    Trial Locations
    Saint Luke's Hospital
    Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
    Toledo Clinic Cancer Centers-Maumee
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Pemetrexed or Erlotinib as Second-Line Therapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Northwest Ohio Oncology Center

    Trial Locations
    Northwest Ohio Oncology Center
    Saint Luke's Hospital
    Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Toledo Clinic Cancer Centers-Maumee
    Maumee, Ohio 43537-1839
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct
    Northwest Ohio Oncology Center
    Maumee, Ohio 43537
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
    Saint Luke's Hospital

    Trial Locations
    Saint Luke's Hospital
    Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
    Toledo Clinic Cancer Centers-Maumee
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer
    Acute Pain Caused by Paclitaxel in Patients With Cancer
    Northwest Ohio Oncology Center
    Maumee, Ohio 43537
    Chemotherapeutic Agent Toxicity, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    Saint Luke's Hospital

    Trial Locations
    Saint Luke's Hospital
    Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
    Toledo Clinic Cancer Centers-Maumee
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
    Northwest Ohio Oncology Center
    Maumee, Ohio 43537
    Breast Cancer, Lung Cancer, Metastatic Cancer, Multiple Myeloma, Plasma Cell Neoplasm, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
    St. Luke's Hospital

    Trial Locations
    St. Luke's Hospital
    Northwest Ohio Oncology Center
    Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific
    Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Saint Luke's Hospital

    Trial Locations
    Saint Luke's Hospital
    Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer